\select@language {UKenglish}
\select@language {UKenglish}
\contentsline {chapter}{Abbreviations}{xvi}{section*.4}
\contentsline {chapter}{\numberline {1}Introduction and Literature Review}{1}{chapter.1}
\contentsline {section}{\numberline {1.1}Cancer Research in the Post-Genomic Era}{1}{section.1.1}
\contentsline {subsection}{\numberline {1.1.1}Cancer is a Global Health Issue}{2}{subsection.1.1.1}
\contentsline {subsubsection}{\numberline {1.1.1.1}The Genetics and Molecular Biology of Cancers}{3}{subsubsection.1.1.1.1}
\contentsline {subsection}{\numberline {1.1.2}The Genomics Revolution in Cancer Research}{3}{subsection.1.1.2}
\contentsline {subsubsection}{\numberline {1.1.2.1}High-Throughput Technologies}{4}{subsubsection.1.1.2.1}
\contentsline {subsubsection}{\numberline {1.1.2.2}Bioinformatics and Genomic Data}{5}{subsubsection.1.1.2.2}
\contentsline {subsection}{\numberline {1.1.3}Genomics Projects}{5}{subsection.1.1.3}
\contentsline {subsubsection}{\numberline {1.1.3.1}The Cancer Genome Project}{6}{subsubsection.1.1.3.1}
\contentsline {subsubsection}{\numberline {1.1.3.2}The Cancer Genome Atlas Project}{6}{subsubsection.1.1.3.2}
\contentsline {subsection}{\numberline {1.1.4}Genomic Cancer Medicine}{8}{subsection.1.1.4}
\contentsline {subsubsection}{\numberline {1.1.4.1}Cancer Genes and Driver Mutations}{8}{subsubsection.1.1.4.1}
\contentsline {subsubsection}{\numberline {1.1.4.2}Precision Cancer Medicine}{9}{subsubsection.1.1.4.2}
\contentsline {subsubsection}{\numberline {1.1.4.3}Molecular Diagnostics and Pan-Cancer Medicine}{9}{subsubsection.1.1.4.3}
\contentsline {subsubsection}{\numberline {1.1.4.4}Targeted Therapeutics and Pharmacogenomics}{10}{subsubsection.1.1.4.4}
\contentsline {subsection}{\numberline {1.1.5}Systems and Network Biology}{11}{subsection.1.1.5}
\contentsline {section}{\numberline {1.2}Synthetic Lethal Cancer Medicine}{12}{section.1.2}
\contentsline {subsection}{\numberline {1.2.1}Synthetic Lethal Genetic Interactions}{13}{subsection.1.2.1}
\contentsline {subsection}{\numberline {1.2.2}Synthetic Lethal Concepts in Genetics}{13}{subsection.1.2.2}
\contentsline {subsection}{\numberline {1.2.3}Synthetic Lethality in Model Systems}{15}{subsection.1.2.3}
\contentsline {subsubsection}{\numberline {1.2.3.1}Synthetic Lethal Pathways and Networks}{15}{subsubsection.1.2.3.1}
\contentsline {subsubsection}{\numberline {1.2.3.2}Evolution of Synthetic Lethality}{16}{subsubsection.1.2.3.2}
\contentsline {subsection}{\numberline {1.2.4}Synthetic Lethality in Cancer}{17}{subsection.1.2.4}
\contentsline {subsection}{\numberline {1.2.5}Clinical Impact of Synthetic Lethality in Cancer}{18}{subsection.1.2.5}
\contentsline {subsection}{\numberline {1.2.6}High{}-throughput Screening for Synthetic Lethality}{20}{subsection.1.2.6}
\contentsline {subsubsection}{\numberline {1.2.6.1}Synthetic Lethal Screens}{21}{subsubsection.1.2.6.1}
\contentsline {subsection}{\numberline {1.2.7}Computational Prediction of Synthetic Lethality}{22}{subsection.1.2.7}
\contentsline {subsubsection}{\numberline {1.2.7.1}Bioinformatics Approaches to Genetic Interactions}{22}{subsubsection.1.2.7.1}
\contentsline {subsubsection}{\numberline {1.2.7.2}Comparative Genomics}{24}{subsubsection.1.2.7.2}
\contentsline {subsubsection}{\numberline {1.2.7.3}Analysis and Modelling of Protein Data}{26}{subsubsection.1.2.7.3}
\contentsline {subsubsection}{\numberline {1.2.7.4}Differential Gene Expression}{28}{subsubsection.1.2.7.4}
\contentsline {subsubsection}{\numberline {1.2.7.5}Data Mining and Machine Learning}{29}{subsubsection.1.2.7.5}
\contentsline {subsubsection}{\numberline {1.2.7.6}Mutual Exclusivity and Bimodality}{32}{subsubsection.1.2.7.6}
\contentsline {subsubsection}{\numberline {1.2.7.7}Rationale for Further Development}{33}{subsubsection.1.2.7.7}
\contentsline {section}{\numberline {1.3}E-cadherin as a Synthetic Lethal Target}{33}{section.1.3}
\contentsline {subsection}{\numberline {1.3.1}The \textit {CDH1} gene and its Biological Functions}{34}{subsection.1.3.1}
\contentsline {subsection}{\numberline {1.3.2}Hereditary Diffuse Gastric (and Lobular Breast) Cancer}{35}{subsection.1.3.2}
\contentsline {subsection}{\numberline {1.3.3}Cell Line Models of \textit {CDH1} Null Mutations}{36}{subsection.1.3.3}
\contentsline {section}{\numberline {1.4}Summary and Research Direction of Thesis}{36}{section.1.4}
\contentsline {subsection}{\numberline {1.4.1}Thesis Aims}{37}{subsection.1.4.1}
\contentsline {chapter}{\numberline {2}Methods and Resources}{38}{chapter.2}
\contentsline {section}{\numberline {2.1}Bioinformatics Resources for Genomics Research}{38}{section.2.1}
\contentsline {subsection}{\numberline {2.1.1}Public Data and Software Packages}{38}{subsection.2.1.1}
\contentsline {subsubsection}{\numberline {2.1.1.1}Cancer Genome Atlas Data}{39}{subsubsection.2.1.1.1}
\contentsline {subsubsection}{\numberline {2.1.1.2}Reactome and Annotation Data}{40}{subsubsection.2.1.1.2}
\contentsline {section}{\numberline {2.2}Data Handling}{40}{section.2.2}
\contentsline {subsection}{\numberline {2.2.1}Normalisation}{40}{subsection.2.2.1}
\contentsline {subsection}{\numberline {2.2.2}Sample Triage}{40}{subsection.2.2.2}
\contentsline {subsection}{\numberline {2.2.3}Metagenes and the Singular Value Decomposition}{42}{subsection.2.2.3}
\contentsline {subsection}{\numberline {2.2.4}Candidate Triage and Integration with Screen Data}{43}{subsection.2.2.4}
\contentsline {section}{\numberline {2.3}Techniques}{44}{section.2.3}
\contentsline {subsection}{\numberline {2.3.1}Statistical Procedures and Tests}{44}{subsection.2.3.1}
\contentsline {subsection}{\numberline {2.3.2}Gene Set Over-representation Analysis}{45}{subsection.2.3.2}
\contentsline {subsection}{\numberline {2.3.3}Clustering}{45}{subsection.2.3.3}
\contentsline {subsection}{\numberline {2.3.4}Heatmap}{46}{subsection.2.3.4}
\contentsline {subsection}{\numberline {2.3.5}Modelling and Simulations}{46}{subsection.2.3.5}
\contentsline {subsubsection}{\numberline {2.3.5.1}Receiver Operating Characteristic Curves}{47}{subsubsection.2.3.5.1}
\contentsline {subsection}{\numberline {2.3.6}Resampling Analysis}{48}{subsection.2.3.6}
\contentsline {section}{\numberline {2.4}Pathway Structure Methods}{49}{section.2.4}
\contentsline {subsection}{\numberline {2.4.1}Network and Graph Analysis}{49}{subsection.2.4.1}
\contentsline {subsection}{\numberline {2.4.2}Sourcing Graph Structure Data}{50}{subsection.2.4.2}
\contentsline {subsection}{\numberline {2.4.3}Constructing Pathway Subgraphs}{50}{subsection.2.4.3}
\contentsline {subsection}{\numberline {2.4.4}Network Analysis Metrics}{50}{subsection.2.4.4}
\contentsline {section}{\numberline {2.5}Implementation}{51}{section.2.5}
\contentsline {subsection}{\numberline {2.5.1}Computational Resources and Linux Utilities}{51}{subsection.2.5.1}
\contentsline {subsection}{\numberline {2.5.2}R Language and Packages}{52}{subsection.2.5.2}
\contentsline {subsection}{\numberline {2.5.3}High Performance and Parallel Computing}{54}{subsection.2.5.3}
\contentsline {chapter}{\numberline {3}Methods Developed During Thesis}{56}{chapter.3}
\contentsline {section}{\numberline {3.1}A Synthetic Lethal Detection Methodology}{56}{section.3.1}
\contentsline {section}{\numberline {3.2}Synthetic Lethal Simulation and Modelling}{58}{section.3.2}
\contentsline {subsection}{\numberline {3.2.1}A Model of Synthetic Lethality in Expression Data}{59}{subsection.3.2.1}
\contentsline {subsection}{\numberline {3.2.2}Simulation Procedure}{63}{subsection.3.2.2}
\contentsline {section}{\numberline {3.3}Detecting Simulated Synthetic Lethal Partners}{66}{section.3.3}
\contentsline {subsection}{\numberline {3.3.1}Binomial Simulation of Synthetic Lethality}{66}{subsection.3.3.1}
\contentsline {subsection}{\numberline {3.3.2}Multivariate Normal Simulation of Synthetic Lethality}{68}{subsection.3.3.2}
\contentsline {subsubsection}{\numberline {3.3.2.1}Multivariate Normal Simulation with Correlated Genes}{70}{subsubsection.3.3.2.1}
\contentsline {subsubsection}{\numberline {3.3.2.2}Specificity with Query-Correlated Pathways}{78}{subsubsection.3.3.2.2}
\contentsline {section}{\numberline {3.4}Graph Structure Methods}{80}{section.3.4}
\contentsline {subsection}{\numberline {3.4.1}Upstream and Downstream Gene Detection}{80}{subsection.3.4.1}
\contentsline {subsubsection}{\numberline {3.4.1.1}Permutation Analysis for Statistical Significance}{81}{subsubsection.3.4.1.1}
\contentsline {subsection}{\numberline {3.4.2}Simulating Gene Expression from Graph Structures}{82}{subsection.3.4.2}
\contentsline {section}{\numberline {3.5}Customised Functions and Packages Developed}{87}{section.3.5}
\contentsline {subsection}{\numberline {3.5.1}Synthetic Lethal Interaction Prediction Tool}{87}{subsection.3.5.1}
\contentsline {subsection}{\numberline {3.5.2}Data Visualisation}{88}{subsection.3.5.2}
\contentsline {subsection}{\numberline {3.5.3}Extensions to the iGraph Package}{88}{subsection.3.5.3}
\contentsline {subsubsection}{\numberline {3.5.3.1}Sampling Simulated Data from Graph Structures}{89}{subsubsection.3.5.3.1}
\contentsline {subsubsection}{\numberline {3.5.3.2}Plotting Directed Graph Structures}{90}{subsubsection.3.5.3.2}
\contentsline {subsubsection}{\numberline {3.5.3.3}Computing Information Centrality}{91}{subsubsection.3.5.3.3}
\contentsline {subsubsection}{\numberline {3.5.3.4}Testing Pathway Structure with Permutation Testing}{92}{subsubsection.3.5.3.4}
\contentsline {subsubsection}{\numberline {3.5.3.5}Metapackage to Install iGraph Functions}{92}{subsubsection.3.5.3.5}
\contentsline {chapter}{\numberline {4}Synthetic Lethal Analysis of Gene Expression Data}{93}{chapter.4}
\contentsline {section}{\numberline {4.1}Synthetic Lethal Genes in Breast Cancer}{94}{section.4.1}
\contentsline {subsection}{\numberline {4.1.1}Synthetic Lethal Pathways in Breast Cancer}{95}{subsection.4.1.1}
\contentsline {subsection}{\numberline {4.1.2}Expression Profiles of Synthetic Lethal Partners}{98}{subsection.4.1.2}
\contentsline {subsubsection}{\numberline {4.1.2.1}Subgroup Pathway Analysis}{101}{subsubsection.4.1.2.1}
\contentsline {section}{\numberline {4.2}Comparing Synthetic Lethal Gene Candidates}{104}{section.4.2}
\contentsline {subsection}{\numberline {4.2.1}Primary siRNA Screen Candidates}{104}{subsection.4.2.1}
\contentsline {subsection}{\numberline {4.2.2}Comparison with Correlation}{104}{subsection.4.2.2}
\contentsline {subsection}{\numberline {4.2.3}Comparison with Primary Screen Viability}{107}{subsection.4.2.3}
\contentsline {subsection}{\numberline {4.2.4}Comparison with Secondary siRNA Screen Validation}{109}{subsection.4.2.4}
\contentsline {subsection}{\numberline {4.2.5}Comparison to Primary Screen at Pathway Level}{110}{subsection.4.2.5}
\contentsline {subsubsection}{\numberline {4.2.5.1}Resampling Genes for Pathway Enrichment}{112}{subsubsection.4.2.5.1}
\contentsline {subsection}{\numberline {4.2.6}Integrating Synthetic Lethal Pathways and Screens}{118}{subsection.4.2.6}
\contentsline {section}{\numberline {4.3}Synthetic Lethal Pathway Metagenes}{119}{section.4.3}
\contentsline {section}{\numberline {4.4}\leavevmode {\color {red}Application of SLIPT to } Stomach Cancer}{121}{section.4.4}
\contentsline {subsection}{\numberline {4.4.1}\leavevmode {\color {black}Synthetic Lethal Genes and Pathways}}{122}{subsection.4.4.1}
\contentsline {subsection}{\numberline {4.4.2}\leavevmode {\color {black}Synthetic Lethal Expression Profiles}}{122}{subsection.4.4.2}
\contentsline {subsection}{\numberline {4.4.3}\leavevmode {\color {black}Comparison to Primary Screen}}{127}{subsection.4.4.3}
\contentsline {subsubsection}{\numberline {4.4.3.1}\leavevmode {\color {black}Resampling Analysis}}{130}{subsubsection.4.4.3.1}
\contentsline {subsection}{\numberline {4.4.4}\leavevmode {\color {black}Metagene Analysis}}{133}{subsection.4.4.4}
\contentsline {section}{\numberline {4.5}Discussion}{134}{section.4.5}
\contentsline {subsection}{\numberline {4.5.1}Strengths of the SLIPT Methodology}{134}{subsection.4.5.1}
\contentsline {subsection}{\numberline {4.5.2}Synthetic Lethal Pathways for E-cadherin}{135}{subsection.4.5.2}
\contentsline {subsection}{\numberline {4.5.3}Replication and Validation}{137}{subsection.4.5.3}
\contentsline {subsubsection}{\numberline {4.5.3.1}Integration with siRNA Screening}{137}{subsubsection.4.5.3.1}
\contentsline {subsubsection}{\numberline {4.5.3.2}\leavevmode {\color {black}Comparison across Tissues}}{137}{subsubsection.4.5.3.2}
\contentsline {section}{\numberline {4.6}Summary}{138}{section.4.6}
\contentsline {chapter}{\numberline {5}Synthetic Lethal Pathway Structure}{140}{chapter.5}
\contentsline {section}{\numberline {5.1}Synthetic Lethal Genes in Reactome Pathways}{140}{section.5.1}
\contentsline {subsection}{\numberline {5.1.1}The PI3K/AKT Pathway}{141}{subsection.5.1.1}
\contentsline {subsection}{\numberline {5.1.2}The Extracellular Matrix}{143}{subsection.5.1.2}
\contentsline {subsection}{\numberline {5.1.3}G Protein Coupled Receptors}{144}{subsection.5.1.3}
\contentsline {subsection}{\numberline {5.1.4}Gene Regulation and Translation}{145}{subsection.5.1.4}
\contentsline {section}{\numberline {5.2}Network Analysis of Synthetic Lethal Genes}{146}{section.5.2}
\contentsline {subsection}{\numberline {5.2.1}Gene Connectivity and Vertex Degree}{147}{subsection.5.2.1}
\contentsline {subsection}{\numberline {5.2.2}Gene Importance and Centrality}{149}{subsection.5.2.2}
\contentsline {subsubsection}{\numberline {5.2.2.1}Information Centrality}{149}{subsubsection.5.2.2.1}
\contentsline {subsubsection}{\numberline {5.2.2.2}PageRank Centrality}{150}{subsubsection.5.2.2.2}
\contentsline {section}{\numberline {5.3}Relationships between Synthetic Lethal Genes}{152}{section.5.3}
\contentsline {subsection}{\numberline {5.3.1}Detecting Upstream or Downstream Synthetic Lethality}{152}{subsection.5.3.1}
\contentsline {subsection}{\numberline {5.3.2}Resampling for Synthetic Lethal Pathway Structure}{155}{subsection.5.3.2}
\contentsline {section}{\numberline {5.4}Discussion}{157}{section.5.4}
\contentsline {section}{\numberline {5.5}Summary}{159}{section.5.5}
\contentsline {chapter}{\numberline {6}Simulation and Modelling of Synthetic Lethal Pathways}{161}{chapter.6}
\contentsline {section}{\numberline {6.1}Synthetic Lethal Detection Methods}{162}{section.6.1}
\contentsline {subsection}{\numberline {6.1.1}Performance of SLIPT and $\chi ^2$ across Quantiles}{162}{subsection.6.1.1}
\contentsline {subsubsection}{\numberline {6.1.1.1}Correlated Query Genes affects Specificity}{165}{subsubsection.6.1.1.1}
\contentsline {subsection}{\numberline {6.1.2}Alternative Synthetic Lethal Detection Strategies}{167}{subsection.6.1.2}
\contentsline {subsubsection}{\numberline {6.1.2.1}Correlation for Synthetic Lethal Detection}{168}{subsubsection.6.1.2.1}
\contentsline {subsubsection}{\numberline {6.1.2.2}Testing for Bimodality with BiSEp}{168}{subsubsection.6.1.2.2}
\contentsline {section}{\numberline {6.2}Simulations with Graph structures}{170}{section.6.2}
\contentsline {subsection}{\numberline {6.2.1}Performance over Graph structures}{171}{subsection.6.2.1}
\contentsline {subsubsection}{\numberline {6.2.1.1}Simple Graph structures}{171}{subsubsection.6.2.1.1}
\contentsline {subsubsection}{\numberline {6.2.1.2}Constructed Graph structures}{172}{subsubsection.6.2.1.2}
\contentsline {subsection}{\numberline {6.2.2}Performance with Inhibitions}{173}{subsection.6.2.2}
\contentsline {subsection}{\numberline {6.2.3}Synthetic Lethality across Graph structures}{183}{subsection.6.2.3}
\contentsline {subsection}{\numberline {6.2.4}Performance within a Large Simulated Dataset}{185}{subsection.6.2.4}
\contentsline {section}{\numberline {6.3}Simulations in More Complex Graph structures}{189}{section.6.3}
\contentsline {subsection}{\numberline {6.3.1}Simulations over Pathway-based Graphs}{190}{subsection.6.3.1}
\contentsline {subsection}{\numberline {6.3.2}Pathway Structures in a Large Simulated Dataset}{192}{subsection.6.3.2}
\contentsline {section}{\numberline {6.4}Discussion}{194}{section.6.4}
\contentsline {subsection}{\numberline {6.4.1}Simulation Procedure}{194}{subsection.6.4.1}
\contentsline {subsection}{\numberline {6.4.2}Comparing Methods with Simulated Data}{195}{subsection.6.4.2}
\contentsline {subsection}{\numberline {6.4.3}Design and Performance of SLIPT}{197}{subsection.6.4.3}
\contentsline {subsection}{\numberline {6.4.4}Simulations from Graph structures}{199}{subsection.6.4.4}
\contentsline {section}{\numberline {6.5}Summary}{200}{section.6.5}
\contentsline {chapter}{\numberline {7}Discussion}{201}{chapter.7}
\contentsline {section}{\numberline {7.1}Synthetic Lethality and \textit {CDH1} Biology}{201}{section.7.1}
\contentsline {subsection}{\numberline {7.1.1}Established Functions of \textit {CDH1}}{202}{subsection.7.1.1}
\contentsline {subsection}{\numberline {7.1.2}The Molecular Role of \textit {CDH1} in Cancer}{202}{subsection.7.1.2}
\contentsline {section}{\numberline {7.2}Significance}{203}{section.7.2}
\contentsline {subsection}{\numberline {7.2.1}Synthetic Lethality in the Genomic Era}{203}{subsection.7.2.1}
\contentsline {subsection}{\numberline {7.2.2}Clinical Interventions based on Synthetic Lethality}{205}{subsection.7.2.2}
\contentsline {section}{\numberline {7.3}Future Directions}{206}{section.7.3}
\contentsline {section}{\numberline {7.4}Conclusions}{208}{section.7.4}
\contentsline {chapter}{\hbox to\@tempdima {\hfil }Bibliography}{211}{section.7.4}
\contentsline {chapter}{\numberline {A}Data Quality}{235}{appendix.A}
\contentsline {section}{\numberline {A.1}\leavevmode {\color {black}Pathway Overlap}}{235}{section.A.1}
\contentsline {section}{\numberline {A.2}Sample Correlation}{236}{section.A.2}
\contentsline {section}{\numberline {A.3}Replicate Samples in TCGA Breast Cancer Data}{238}{section.A.3}
\contentsline {chapter}{\numberline {B}Software Used for Thesis}{242}{appendix.B}
\contentsline {chapter}{\numberline {C}Mutation Analysis in Breast Cancer}{252}{appendix.C}
\contentsline {section}{\numberline {C.1}Synthetic Lethal Genes and Pathways}{252}{section.C.1}
\contentsline {section}{\numberline {C.2}Synthetic Lethal Expression Profiles}{253}{section.C.2}
\contentsline {section}{\numberline {C.3}Comparison to Primary Screen}{257}{section.C.3}
\contentsline {subsection}{\numberline {C.3.1}Resampling Analysis}{259}{subsection.C.3.1}
\contentsline {section}{\numberline {C.4}Compare SLIPT genes}{260}{section.C.4}
\contentsline {chapter}{\numberline {D}Metagene Analysis}{262}{appendix.D}
\contentsline {section}{\numberline {D.1}Pathway Signature Expression}{262}{section.D.1}
\contentsline {section}{\numberline {D.2}Synthetic Lethal Reactome Metagenes}{266}{section.D.2}
\contentsline {chapter}{\numberline {E}Intrinsic Subtyping}{267}{appendix.E}
\contentsline {chapter}{\numberline {F}Synthetic Lethal Genes in Pathways}{269}{appendix.F}
\contentsline {chapter}{\numberline {G}Network Analysis for Mutation SLIPT}{293}{appendix.G}
\contentsline {chapter}{\numberline {H}Pathway Structure for Mutation SLIPT}{296}{appendix.H}
\contentsline {chapter}{\numberline {I}Performance of SLIPT and $\chi ^2$}{298}{appendix.I}
\contentsline {section}{\numberline {I.1}Correlated Query Genes affects Specificity}{304}{section.I.1}
\contentsline {chapter}{\numberline {J}Simulations on Graph Structures}{310}{appendix.J}
\contentsline {section}{\numberline {J.1}Simulations from Inhibiting Graph Structures}{311}{section.J.1}
\contentsline {section}{\numberline {J.2}Simulation across Graph Structures}{314}{section.J.2}
\contentsline {section}{\numberline {J.3}Simulations within a Large Simulated Dataset}{318}{section.J.3}
\contentsline {section}{\numberline {J.4}Simulations from Complex Graph Structures}{319}{section.J.4}
\contentsline {section}{\numberline {J.5}Simulations from Complex Inhibiting Graphs}{322}{section.J.5}
\contentsline {section}{\numberline {J.6}Simulations from Pathway Graph Structures}{328}{section.J.6}
